Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kylozyme
- Development stage
- Preclinical
- Lead developer
- Kylon Remedies
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Kylozyme is an oral digestive tonic syrup developed by Kylon Remedies. It is designed to manage gastrointestinal symptoms including bloating, chronic indigestion, and poor nutrient absorption. Although the exact composition of the syrup is not fully disclosed in pipeline records, its nomenclature suggests an enzyme-based formulation aimed at enhancing digestive function and nutrient uptake.
- Brand names
- Kylozyme
- Other names
- KYLOZYME Syrup
Beyond the preview
Go deeper on Kylozyme.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kylozyme.